Filtros de búsqueda

Lista de obras de Roswitha Forstpointner

Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymp

artículo científico publicado en 2016

Confirmation of the mantle-cell lymphoma International Prognostic Index in randomized trials of the European Mantle-Cell Lymphoma Network

artículo científico publicado en 2014

Nine months to progression using fourth-line liposomally encapsulated paclitaxel against hepatocellular carcinoma

artículo científico publicado en 2008

Open-label, Randomized Study of Pegfilgrastim vs. Daily Filgrastim as an Adjunct to Chemotherapy in Elderly Patients with Non-Hodgkin's Lymphoma ⬇️

artículo científico publicado el 1 de septiembre de 2003

Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma Network

artículo científico publicado en 2016

Rituximab maintenance therapy in follicular lymphoma

artículo científico publicado en 2007

Rituximab maintenance versus radioimmunotherapy consolidation in follicular lymphoma: which, when, and for whom?

artículo científico publicado en 2011

The addition of rituximab to a combination of fludarabine, cyclophosphamide, mitoxantrone (FCM) significantly increases the response rate and prolongs survival as compared with FCM alone in patients with relapsed and refractory follicular and mantle

artículo científico publicado en 2004

Treatment strategies in follicular lymphomas: current status and future perspectives

artículo científico publicado en 2005

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda